miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I

被引：49

作者：

Song, Bin ^{[1
]}

Ji, Weiping ^{[1
]}

Gu, Shiwei ^{[1
]}

Liu, Anan ^{[1
]}

Jing, Wei ^{[1
]}

Shao, Chenghao ^{[1
]}

Li, Gang ^{[1
]}

Jin, Gang ^{[1
]}

机构：

[1] Second Mil Med Univ, Dept Pancreat Surg, Changhai Hosp, Shanghai 200082, Peoples R China

来源：

FEBS LETTERS | 2014年 / 588卷 / 23期

基金：

上海市自然科学基金;

关键词：

miR-545; Pancreatic ductal adenocarcinoma; RIG-I; Patients survival; Cancer growth; HEPATOCELLULAR-CARCINOMA; MICRORNAS; CANCER; RECOGNITION; SURVIVAL; RNA; ACTIVATION; APOPTOSIS; GENES; CELLS;

D O I：

10.1016/j.febslet.2014.10.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) ranks fourth on the list of cancer-related causes of death. Deregulation or dysfunction of miRNAs contribute to cancer development. In this study, we found that low miR-545 level and high RIG-I protein in PDAC tissues were both correlated with low survival rate. MiR-545 up-regulation inhibited PDAC cell lines growth and vice versa. 3'UTR of RIG-I was targeted by miR-545. Thus we concluded that low miR-545 levels in PDAC promote tumor cells growth, and this is associated with reduced survival in PDAC patients. MiR-545 exerts its effects by directly targeting RIG-1. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：4375 / 4381

页数：7

共 50 条

[1] MiR-940 Inhibited Pancreatic Ductal Adenocarcinoma Growth by Targeting MyD88
Song, Bin
Zhang, Chaoxiong
Li, Gang
Jin, Gang
Liu, Cong
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (03) : 1167 - 1177
[2] Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma
Liu, Zhikui
Dou, Changwei
Yao, Bowen
Xu, Meng
Ding, Linglong
Wang, Yufeng
Jia, Yuli
Li, Qing
Zhang, Hongyong
Tu, Kangsheng
Song, Tao
Liu, Qingguang
ONCOTARGET, 2016, 7 (18) : 25350 - 25365
[3] MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1
Song, Bin
Zheng, Kailian
Ma, Hongyun
Liu, Anan
Jing, Wei
Shao, Chenghao
Li, Gang
Jin, Gang
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (05) : 1846 - 1856
[4] Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma
Li, He
Xiang, Heping
Ge, Weiwei
Wang, Hengtong
Wang, Tianpeng
Xiong, Maoming
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12313 - 12318
[5] Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
Singh, Gurkaranjot
Kutcher, Drew
Lally, Rajeshwar
Rai, Vikrant
CANCERS, 2024, 16 (11)
[6] MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro
Huang, Feng-Ting
Peng, Juan-Fei
Cheng, Wen-Jie
Zhuang, Yan-Yan
Wang, Ling-Yun
Li, Chu-Qiang
Tang, Jian
Chen, Wen-Ying
Li, Yuan-Hua
Zhang, Shi-Neng
DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (04) : 944 - 957
[7] Porcine epidemic diarrhea virus nsp14 inhibited IFN-I production by targeting RIG-I for degradation
Li, Shasha
Wang, Linhao
Wen, Yanqiao
Han, Jinyuan
Hou, Jixia
Hou, Zhengyang
Xie, Jingying
Li, Huixia
Li, Xiangrong
Yang, Yanmei
Feng, Ruofei
VIROLOGY, 2025, 605
[8] Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
Bek, Sarah
Stritzke, Florian
Wintges, Alexander
Nedelko, Tatiana
Boehmer, Daniel F. R.
Fischer, Julius C.
Haas, Tobias
Poeck, Hendrik
Heidegger, Simon
ONCOIMMUNOLOGY, 2019, 8 (04):
[9] Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma
Zhang, Jing
Zhao, Chen-Yan
Zhang, Shu-Hui
Yu, Dang-Hui
Chen, Ying
Liu, Qing-Hua
Shi, Min
Ni, Can-Rong
Zhu, Ming-Hua
ONCOLOGY REPORTS, 2014, 31 (03) : 1157 - 1164
[10] Targeted Nanoparticle Delivery of Bifunctional RIG-I Agonists to Pancreatic Cancer
Zillinger, Thomas
Hartmann, Gunther
MOLECULAR THERAPY, 2019, 27 (03) : 491 - 492

← 1 2 3 4 5 →